NCT06894511 2026-04-08
PSMAndARPI
Novartis
Phase 2 Active not recruiting
Clinical Trials
6 trialsNCT03874884 2025-05-14
LuPARP
Peter MacCallum Cancer Centre, Australia
Phase 1 Active not recruiting
NCT05208229 2025-04-01
WB-LuPSMA
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Terminated
NCT03724747 2024-11-08
Study to Evaluate the Safety, Tolerability,Pharmacokinetics, and Antitumor Activity of a Thorium-227 Labeled Antibody-chelator Conjugate Alone and in Combination With Darolutamide, in Patients With Metastatic Castration Resistant Prostate Cancer
Bayer
Phase 1 Completed
NCT05425862 2023-12-11
REPAIR
Peter MacCallum Cancer Centre, Australia
Phase 1 Suspended
NCT04516161 2022-03-31
EPIX
Bayer
Completed